HRP20020810A2 - Novel lhrh-antagonists, production and use thereof as medicament - Google Patents

Novel lhrh-antagonists, production and use thereof as medicament Download PDF

Info

Publication number
HRP20020810A2
HRP20020810A2 HRP20020810A HRP20020810A2 HR P20020810 A2 HRP20020810 A2 HR P20020810A2 HR P20020810 A HRP20020810 A HR P20020810A HR P20020810 A2 HRP20020810 A2 HR P20020810A2
Authority
HR
Croatia
Prior art keywords
lys
nal
pal
compound
tyr5
Prior art date
Application number
Other languages
English (en)
Croatian (hr)
Inventor
Michael Bernd
Bernhard Kutscher
Eckhard Guenther
Peter Romeis
Thomas Reissmann
Thomas Beckers
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/525,007 external-priority patent/US6627609B1/en
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of HRP20020810A2 publication Critical patent/HRP20020810A2/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/23Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HRP20020810 2000-03-14 2001-03-12 Novel lhrh-antagonists, production and use thereof as medicament HRP20020810A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/525,007 US6627609B1 (en) 1999-03-17 2000-03-14 LHRH antagonists having improved solubility properties
PCT/EP2001/002719 WO2001068676A2 (fr) 2000-03-14 2001-03-12 Nouveaux antagonistes de la lhrh, sa production et son utilisation comme medicament

Publications (1)

Publication Number Publication Date
HRP20020810A2 true HRP20020810A2 (en) 2004-12-31

Family

ID=24091545

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20020810 HRP20020810A2 (en) 2000-03-14 2001-03-12 Novel lhrh-antagonists, production and use thereof as medicament

Country Status (25)

Country Link
EP (1) EP1268522B1 (fr)
JP (1) JP3805679B2 (fr)
KR (1) KR100607396B1 (fr)
CN (2) CN1443195A (fr)
AT (1) ATE408619T1 (fr)
AU (2) AU6011001A (fr)
BG (1) BG107121A (fr)
BR (1) BR0109279A (fr)
CA (1) CA2402193C (fr)
DE (1) DE50114335D1 (fr)
DK (1) DK1268522T3 (fr)
ES (1) ES2312435T3 (fr)
HR (1) HRP20020810A2 (fr)
HU (1) HUP0300222A3 (fr)
IL (1) IL151647A0 (fr)
MX (1) MXPA02008870A (fr)
NO (1) NO20024363L (fr)
NZ (1) NZ521273A (fr)
PL (1) PL357999A1 (fr)
PT (1) PT1268522E (fr)
RU (1) RU2248982C9 (fr)
SK (1) SK14332002A3 (fr)
UA (1) UA79070C2 (fr)
WO (1) WO2001068676A2 (fr)
ZA (1) ZA200207248B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100340572C (zh) * 2004-12-01 2007-10-03 中国人民解放军军事医学科学院毒物药物研究所 新的lhrh拮抗剂
CN101037472B (zh) * 2006-03-14 2013-03-27 中国人民解放军军事医学科学院毒物药物研究所 具有低组胺释放作用的促黄体生成素释放激素拮抗剂
KR101863136B1 (ko) 2008-01-24 2018-05-31 에스퍼란스 파마슈티컬스, 인코포레이티드 용해 도메인 융합 구성물 및 이를 제조하고 사용하는 방법
TWI442932B (zh) * 2008-02-11 2014-07-01 Ferring Int Ct Sa 以GnRH拮抗劑治療攝護腺癌的方法
CN101597321B (zh) * 2008-06-03 2013-04-24 中国人民解放军军事医学科学院毒物药物研究所 长效低组胺释放副作用的lhrh拮抗剂
WO2010142060A1 (fr) * 2009-06-11 2010-12-16 中国人民解放军军事医学科学院毒物药物研究所 Antagoniste de la lhrh à longue durée d'action et faible effet de libération d'histamine
WO2014070957A1 (fr) 2012-10-30 2014-05-08 Esperance Pharmaceuticals, Inc. Conjugués anticorps/médicament et leurs procédés d'utilisation
CN104418936B (zh) * 2013-08-20 2018-06-05 中国人民解放军军事医学科学院毒物药物研究所 Lhrh拮抗剂衍生物及其药物用途
FR3024612B1 (fr) * 2014-08-04 2018-03-09 Alstom Transp Tech Module d'alimentation electrique d'un bloc moteur, systeme de traction et vehicule electrique associe
RU2585367C1 (ru) * 2014-11-05 2016-05-27 Наталья Владимировна Спиридонова Способ лечения бесплодия у женщин с миомой матки

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA862570B (en) * 1985-04-09 1986-12-30 Univ Tulane Therapeutic decapeptides
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
US5140009A (en) 1988-02-10 1992-08-18 Tap Pharmaceuticals, Inc. Octapeptide LHRH antagonists
US5300492A (en) 1988-02-10 1994-04-05 Tap Pharmaceuticals LHRH analogs
IL101074A (en) 1991-03-14 1997-09-30 Salk Inst For Biological Studi GnRH ANALOGS AND THEIR PREPARATION
AU1371892A (en) 1991-04-25 1992-12-21 Romano Deghenghi Luteinizing hormone releasing hormone antagonist peptides
RU2043362C1 (ru) * 1991-08-12 1995-09-10 Синтекс (Ю-Эс-Эй) Инк. Способ твердофазного синтеза пептидов
WO1994013313A1 (fr) 1992-12-04 1994-06-23 Abbott Laboratories Antagonistes de l'hormone liberant l'hormone luteinisante (lhrh) de decapeptides modifies en position 6
JP3568952B2 (ja) 1992-12-18 2004-09-22 アボット・ラボラトリーズ 5位及び6位に修飾アミノアシル残基を有するlhrh拮抗薬
IL108509A0 (en) 1993-02-22 1994-05-30 Salk Inst For Biological Studi GnRH antagonist peptides
DE4320201A1 (de) * 1993-06-18 1995-01-12 Asta Medica Ag Verwendung von Cetrorelix und weiteren Nona- und Dekapeptiden zur Herstellung eines Arzneimittels zur Bekämpfung von Aids und zur Wachstumsstimulation
DE19544212A1 (de) * 1995-11-28 1997-06-05 Asta Medica Ag Neue LH-RH-Antagonisten mit verbesserter Wirkung
DE19911771B4 (de) * 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung

Also Published As

Publication number Publication date
EP1268522A2 (fr) 2003-01-02
RU2248982C9 (ru) 2005-06-10
MXPA02008870A (es) 2003-06-24
CN100500692C (zh) 2009-06-17
DK1268522T3 (da) 2009-01-12
DE50114335D1 (de) 2008-10-30
CN1876677A (zh) 2006-12-13
UA79070C2 (en) 2007-05-25
AU6011001A (en) 2001-09-24
ATE408619T1 (de) 2008-10-15
BG107121A (bg) 2003-05-30
JP3805679B2 (ja) 2006-08-02
EP1268522B1 (fr) 2008-09-17
BR0109279A (pt) 2002-12-17
NO20024363L (no) 2002-11-13
RU2248982C2 (ru) 2005-03-27
WO2001068676A2 (fr) 2001-09-20
SK14332002A3 (sk) 2003-09-11
NO20024363D0 (no) 2002-09-12
HUP0300222A2 (hu) 2003-07-28
JP2003535044A (ja) 2003-11-25
IL151647A0 (en) 2003-04-10
WO2001068676A3 (fr) 2002-10-24
PT1268522E (pt) 2008-12-22
CN1443195A (zh) 2003-09-17
KR100607396B1 (ko) 2006-08-02
CA2402193A1 (fr) 2002-09-09
NZ521273A (en) 2005-01-28
HUP0300222A3 (en) 2004-08-30
ZA200207248B (en) 2003-02-21
AU2001260110B2 (en) 2005-05-05
ES2312435T3 (es) 2009-03-01
KR20020083179A (ko) 2002-11-01
CA2402193C (fr) 2010-05-18
PL357999A1 (en) 2004-08-09

Similar Documents

Publication Publication Date Title
AU759442B2 (en) Novel LHRH antagonists with improved solubility characteristics
EP0642530B1 (fr) Derives de dolastatine
CA2402193C (fr) Nouveaux antagonistes de la lhrh, sa production et son utilisation comme medicament
HK1057569A (en) Novel lhrh-antagonists, production and use thereof as medicament
HK1094586A (en) Novel lhrh-antagonist, production and use thereof as medicament

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: ZENTARIS GMBH, DE

ODRP Renewal fee for the maintenance of a patent

Payment date: 20090311

Year of fee payment: 9

ODBI Application refused